18F-fluoroethyl-tyrosine glioma tumor progression positron emission tomography radiomics treatment-related changes

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
30 Dec 2023
Historique:
received: 27 10 2023
revised: 10 12 2023
accepted: 23 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

The follow-up of glioma patients after therapeutic intervention remains a challenging topic, as therapy-related changes can emulate true progression in contrast-enhanced magnetic resonance imaging.

Identifiants

pubmed: 38201621
pii: cancers16010195
doi: 10.3390/cancers16010195
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Begoña Manzarbeitia-Arroba (B)

Nuclear Medicine Department, University Hospital of Toledo, 45007 Toledo, Spain.

Marina Hodolic (M)

Nuclear Medicine Department, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.

Robert Pichler (R)

Institute of Nuclear Medicine Kepler University Hospital-Neuromed Campus, 4020 Linz, Austria.

Olga Osipova (O)

Institute of Nuclear Medicine Kepler University Hospital-Neuromed Campus, 4020 Linz, Austria.

Ángel Maria Soriano-Castrejón (ÁM)

Nuclear Medicine Department, University Hospital of Toledo, 45007 Toledo, Spain.

Ana María García-Vicente (AM)

Nuclear Medicine Department, University Hospital of Toledo, 45007 Toledo, Spain.

Classifications MeSH